Literature DB >> 23742759

Associations between genetic polymorphisms of paraoxonase genes and coronary artery disease in a Taiwanese population.

Chi-Ching Chen1, Chien-Chung Chen, Jun-Da Tu, Yi-Ling Wu, Sy-Jye Leu.   

Abstract

OBJECTIVE: We evaluated the relationship between polymorphisms of the paraoxonase (PON) gene and the risk of coronary artery disease (CAD) in Taiwanese patients.
METHODS: Our sample set included 369 volunteers, classified into two groups: 162 healthy volunteers and 207 CAD patients aged 60.0 ± 9.7 and 64.3 ± 12.3 years, respectively. Polymorphisms of the PON1 and PON2 genes were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) techniques.
RESULTS: The results indicate that for the PON1 gene, the homozygous genotype RR was found significantly more often among the CAD group compared with the healthy group (OR=1.965, 95% CI=1.223-3.159, p=0.005). Furthermore, for the PON2 gene, the homozygous genotype CC was found significantly more often among the CAD group compared with the control group (OR=2.525, 95% CI=1.103-5.780, p=0.026).
CONCLUSIONS: Individuals homozygous for the R allele of the PON1 gene and the C allele of the PON2 gene are more likely to have an increased risk of CAD.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAD; Gene polymorphisms; PON1; PON2; Paraoxonase

Mesh:

Substances:

Year:  2013        PMID: 23742759     DOI: 10.1016/j.clinbiochem.2013.05.066

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Association Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-Analysis.

Authors:  Min-Li Chen; Hua Zhao; Ning Liao; Zheng-Fu Xie
Journal:  Med Sci Monit       Date:  2016-09-09

2.  Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.

Authors:  Abdelghani Bounafaa; Hicham Berrougui; Noreddine Ghalim; Boubker Nasser; Abdallah Bagri; Abderrahmane Moujahid; Souad Ikhlef; Pamela Camponova; Najoua Yamoul; Olivier Kamtchueng Simo; Abdelkhalid Essamadi; Abdelouahed Khalil
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.